Car.70/Il15-Transduced Cb-Nk Cells
Advanced Osteosarcoma
M.D. Anderson Cancer CenterCell therapyPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Advanced Osteosarcoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Fludarabine M.D. Anderson Cancer Center | Phase 1/2 | CCC |
Same molecule, other indications
Car.70/Il15-Transduced Cb-Nk Cells is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →